Upcoming sickle cell gene therapies cost effective at $2 million, says ICER
Pharmaceutical Technology
APRIL 13, 2023
Although the findings in the report are only preliminary, they shed light at the considerations behind the high price tags of gene therapies. The standard of care for the condition includes blood transfusions, hydroxyurea and iron chelation. million to achieve $150,000 per QALY gained from a healthcare system perspective.
Let's personalize your content